Joby Aviation closes $591 million stock offering with full underwriter option
Investing.com - Exelixis (NASDAQ: EXEL) reported second quarter EPS of $0.75, $0.11 better than the analyst estimate of $0.64. Revenue for the quarter came in at $568.3M versus the consensus estimate of $578.46M.
Guidance
Exelixis sees FY 2025 revenue of $2.25B-$2.35B versus the analyst consensus of $2.34B.
Exelixis’s stock price closed at $44.45. It is up 14.30% in the last 3 months and up 92.34% in the last 12 months.
Exelixis saw 8 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Exelixis’s stock price’s past reactions to earnings here.
According to InvestingPro, Exelixis’s Financial Health score is "great performance".
Check out Exelixis’s recent earnings performance, and Exelixis’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar